Completed Brain & Nervous System Bones, Joints & Muscles

Acute and chronic spinal cord injury: novel studies of synaptogenesis, plasticity and mechanisms of repair

In plain English

AI plain-English summary

Most people with a spinal cord injury regain some movement and sensation in the first year, but no one knows exactly why. This project aims to find out. The problem is that while spontaneous recovery happens, it is always incomplete. The researchers want to understand the biological mechanisms behind this recovery—how damaged nerve fibres regain the ability to conduct signals, and how new connections form between nerve cells. They have an enzyme therapy that can dissolve scar tissue molecules blocking repair, but delivering enough of it to the spinal cord without causing further damage is a challenge. They have developed a new delivery method that gets the enzyme inside scar cells, and will test whether it improves function. They will also use fluorescent probes that light up only when nerve cells are active, to see whether newly sprouted fibres can actually transmit signals. If this works, it could lead to therapies that push recovery further than what happens naturally. The research is fundamental science—it is about understanding the basic biology of spinal cord repair. But that understanding could eventually guide new drugs or treatments that restore more movement and sensation to people with spinal cord injuries.

View original technical description
Spinal cord injury (SCI) leads to severe disability, but in nearly all cases there is some recovery in function over the first year following injury. We intend to find out more about these spontaneous recovery processes in order to try and develop therapies to increase the extent of recovery. For example, using special recording techniques we will study changes in nerve fibre conduction at early and late stages following SCI to see when conduction is compromised and how this changes over time. We have an enzyme therapy which can dissolve molecules that are present in SCI scar tissue. We need to optimise ways of delivering large amounts of this enzyme to the spinal cord while minimising the trauma of repeated administration. We have a new way of delivering the enzyme so that it gets into cells at the spinal cord scar, where it is most needed, and we will test whether this can improve function. We will also use novel techniques to show whether new fibres that have sprouted following this therapy can transmit signals to other nerve cells by studying nerve cell connectivity using special fluorescent probes that light up only when there is activity between cells. Finally we will use techniques to show the molecular signals that change in injured cells when treated with this therapy so that we can target them directly with new drugs. This research will be important for developing therapeutic strategies for treating spinal injured patients.

View the original record at the funder ↗

Researchers

Elizabeth Bradbury (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

The role of neuregulin-1 signalling in modulating repair and functional recovery following spinal cord injury
Identification of novel bioactive mediators of tissue scarring, inflammation and extracellular matrix remodeling after spinal cord injury
Overexpression of neuronal calcium sensor-1 to promote axonal regeneration
A novel vascular approach to recovery of locomotor function after nerve injury
The potential of combining novel silk biomaterial and electric field application for spinal injury repair

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.